Cargando…
Current status and dilemma of second-line treatment in advanced pancreatic cancer: is there a silver lining?
Pancreatic cancer remains one of the most lethal malignant diseases worldwide. The majority of patients present with advanced disease and, therefore, need palliative chemotherapy. Some chemotherapeutic regimens have been well established as first-line therapies and have been shown to increase surviv...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084072/ https://www.ncbi.nlm.nih.gov/pubmed/30122951 http://dx.doi.org/10.2147/OTT.S166405 |